Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Study ID
DFCI 16-716
Status
Direct Oral Anticoagulants (DOACs) versus LMWH +/- Warfarin for
Study ID
DFCI 16-406
Status
Feasibility and safety of avoiding granulocyte colony-stimulating
Study ID
DFCI 15-516
Status
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Study ID
DFCI 16-727
Status
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Study ID
DFCI 16-716
Feasibility and safety of avoiding granulocyte colony-stimulating
Study ID
DFCI 15-516